360 Capital

360 Capital Partners is a Paris-based venture capital firm established in 1997, focusing on seed to series-B investments in consumer goods, business services, deep technology, climate technology, and digital sectors across Europe, particularly in France and Italy. With over 300 million euros under management, the firm has a team that collectively possesses more than 60 years of experience in venture capital, having invested in, supported, and exited from over 110 companies. 360 Capital has built a robust international network by co-investing with leading venture capital funds in more than 10 countries, demonstrating a proven track record of success in diverse economic environments.

Fausto Boni

General Partner

Jean-Baptiste Dumont

General Partner

Jeanne Fritsch

Investor

Selma Gasc

Associate

Lucrezia Lucotti

Partner and Analyst

Celeste Mastria

Investor

Alexandre Mordacq

Partner

Jean-Marie Perrot

CFO

Nader Sabbaghian

Partner

Jessica Vignoles

Investor

Alessandro Zaccaria

Partner

Past deals in Laser

Lithium Lasers

Seed Round in 2021
Manufacturer and supplier of ultra-short pulse lasers intended for material processing, biophotonics, amplifier seeding, micromachining, temporal focusing, and non-linear optics applications. The company offers an optomechanical platform that ensures ultra-low intensity noise and better repetition rate pulses with short durations, enabling clients with beam-pointing stability to reach the right target at every single laser shot.

Thereson

Venture Round in 2014
THERESON S.p.A. is a medical device company based in Vimercate, Italy, established in 2011. The company specializes in developing technologies aimed at treating diabetic foot ulcers. Its primary product, DIAPASON, consists of a console that generates electrical signals and provides an interface for patient interaction, allowing for self-treatment at home. This console connects to emitters that transform the electrical signals into pulsating magnetic fields, employing therapeutic magnetic resonance technology to facilitate systemic treatment and target the ulcer area. THERESON's devices are designed to enhance the interaction between pulsed magnetic fields and damaged biological tissue, particularly benefiting individuals with chronic conditions like diabetes, thereby improving their quality of life and health outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.